Chronology of Committee Work

Rep. Waxman Asks for Hearings on Medicare Cost Estimates, Threatens Suit over Documents

In a letter to Chairman Davis, Rep. Waxman requests a hearing on the allegations that the HHS Actuary was told he would be fired if he shared with Congress estimates on the true costs of the Medicare prescription drug proposal. In a letter to HHS Secretary Thompson, Rep. Waxman threatens legal action under the "Seven Member Rule" if the Secretary continues to refuse to release the cost estimates.

In Light of District Drinking Water Contamination, Members Urge Changes to EPA Lead Rule

Rep. Waxman, Chairman Davis, and Congresswoman Norton urge EPA to address weaknesses in the drinking water lead rule, including the lack of enforceable standards and shortcomings in public notification requirements.

GAO Examines Effectiveness of Missile Defense Testing Program

In a report prepared for Reps. Waxman and Tierney, GAO assesses what is known about the effectiveness of the missile defense system and how the Defense Department's Missile Defense Agency has addressed the Director, Operational Test and Evaluation recommendations on the missile defense testing program.

Rep. Waxman Details Halliburton Audit, Other New Information on Iraq Contracting

At a Committee hearing and in a briefing memo to colleagues, Rep. Waxman details new information from the Defense Contract Audit Agency, GAO, and the Defense Energy Support on Halliburton’s work in Iraq.

NIH Stem Cell Director: Fewer Viable Lines Than Claimed by Administration

Reps. Waxman and Slaughter reveal that the Administration may have misinformed the public about both the number of viable human embryonic stem cell lines available for research and the motivation behind the recent dismissal of a distinguished cell biologist from the President’s Council on Bioethics.

Members Demand Information on Medicare Cost Estimates

In response to reports that the true cost of the Medicare prescription drug legislation was concealed, 19 committee members demand the release of the cost estimates prepared by the Administration during congressional consideration of the legislation.

EPA Questioned on Obligation to Ensure Safe Drinking Water in DC

Rep. Waxman, Chairman Davis, and Congresswoman Norton seek information on whether EPA adequately carried out its responsibility to prevent lead contamination in tap water in the District of Columbia.

Halliburton Unit Reportedly Finds Company Cost Controls "Weak"

Reps. Waxman and Dingell request a copy of Halliburton's internal "Tiger Team" memo which reportedly describes major deficiencies in the company's accounting and control systems.

Drug Manufacturers Asked to Detail Relationships with NIH Scientists

In light of recent reports that top NIH scientists received consulting payments worth hundreds of thousands or even millions of dollars from drug manufacturers with an interest in their work, Reps. Waxman and Sherrod Brown write ten large pharmaceutical manufacturers – Merck, Johnson & Johnson, Wyeth, Schering-Plough, Pfizer, Bristol-MyersSquibb, Eli Lilly, Abbott, Amgen, and Allergan – to request information on their financial arrangements with NIH scientists.

FDA Delays Consideration of Emergency Contraception Drug

Forty eight members of Congress write FDA about the delay in the consideration of the application for over-the-counter status for the emergency contraception drug Plan B.

USDA Urged to Support WIC Fruit and Vegetable Pilot Program

Reps. Waxman and Putnam urge USDA Secretary Veneman to support a pilot program to promote the consumption of fruits and vegetables in the upcoming reauthorization of the Federal Special Supplemental Nutrition Program for Woman, Infants, and Children.

Members Urge DOD to Submit Labor Plan Consistent with Intent of Congress

Rep. Waxman, along with Sens. Lieberman, Levin, Akaka, Durbin, and Reps. Skelton and Danny Davis, express serious concerns about an initial proposal for a new Defense Department labor relations system that effectively eliminates collective bargaining and makes changes to internal union procedures which have no relation to the Department’s national security mission.

Drug Benefits CEO May Have Helped Write Medicare Law Provisions

Reps. Waxman and Sherrod Brown write HHS Secretary Thompson, OMB Director Bolten, and White House Counsel Alberto Gonzales about reports that a pharmaceutical benefits management company CEO may have helped write provisions of the recent Medicare law that govern the prescription drug card program.

Halliburton Fuel Waiver Granted Under Suspect Circumstances

Reps. Waxman and Dingell ask the DOD IG to investigate the December 19 waiver given by the Corps of Engineers to Halliburton, citing new evidence that this unusual waiver -- which relieved Halliburton of its obligation to provide data to justify its high gasoline prices -- may have been awarded on false premises.

Support for California Oyster Ban

Rep. Waxman urges Governor Schwarzenegger to maintain a life-saving ban on the summer sale of raw Gulf Coast Oysters.

Secret Service Questioned on White House Ricin Letter

Rep. Waxman asks about recent reports that the Secret Service waited six days to inform the U.S. Postal Service about the discovery of a ricin-contaminated letter addressed to the White House.

Washington State "Mad Cow" Walked on Day of Slaughter

Reps. Waxman and Tom Davis release eyewitness statements that the cow infected with BSE was not a “downer” cow, as has been claimed – calling into question USDA’s surveillance program for mad cow disease and the agency's credibility.

Whistleblowers: Halliburton Routinely Overcharged

Two Kuwait-based former employees report that Halliburton systematically overpaid for goods and services and then passed these overcharges on to the U.S. taxpayer.

EPA Questioned on Lobbyist Role in Mercury Rulemaking

Reps. Waxman and Allen ask for information on reports that portions of the latest air pollution control proposal may have been copied directly from industry lobbyist memos.

U.S. Role in Evacuating Saudi Citizens Questioned

Rep. Waxman asks about the Justice Department's role in evacuating members of the bin Laden family and other Saudi citizens in the aftermath of September 11, 2001.

President Urged to Ensure Cooperation with Leak Probe

Reps. Waxman and Conyers ask the President about reports that many White House officials are refusing to cooperate with the Justice Department's criminal investigation into the leak of the identity of a covert CIA operative.

Ephedra Substitutes May Pose Dangers

Stimulants sold as ephedra substitutes, not addressed by the pending FDA ban, may have adverse effects comparable to those of ephedra.

Budget Asks for Fraction of Needed AIDS Funding Increase

Eight members call on the Administration to ensure that a new CDC initiative will not leave thousands of Americans with an HIV diagnosis but without access to life saving drugs.

H.R. 2138 Fails to Further Goal of Environmental Protection

Reps. Waxman and Tierney write Subcommittee on Energy Policy Chairman Ose on proposed legislation that would elevate the Environmental Protection Agency to cabinet-level status and makes significant changes to EPA's mission, structure, and authorities.

Administration Asked to Release Medicare Cost Estimates

Ranking Members Waxman, Rangel, and Dingell ask HHS to release cost estimates prepared by the Administration during congressional consideration of the Medicare prescription drug legislation.

Displaying Items 1051 to 1075 of 1458:

Previous Page • Next Page

[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]